Ambulatory blood pressure monitoring in children and adolescents: Coming of age?

Current Hypertension Reports

Volumn 15, Issue 3, 2013, Pages 143-149

  Lurbe, Empar ^a,b   Torró, María Isabel ^a,b   Álvarez, Julio ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

ABPM; Adolescents; Ambulatory blood pressure monitoring; Blood pressure; BP; Children; Hypertension; Masked hypertension; Organ damage; White coat hypertension

Indexed keywords

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHILD HEALTH CARE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LEAN BODY WEIGHT; MASKED HYPERTENSION; ORGAN INJURY; PROGNOSIS; REFERENCE VALUE; RENAL PROTECTION; WHITE COAT HYPERTENSION;

ADOLESCENT; AGE FACTORS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHILD; CHILD, PRESCHOOL; HUMANS; HYPERTENSION; PROGNOSIS;

EID: 84877831462     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-013-0350-7     Document Type: Article

References (60)

1. Lurbe E. Childhood blood pressure: a window to adult hypertension. J Hypertens. 2003;21:2001-3.
2. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens. 1995;8:657-65.
3. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke and coronary heart disease. Part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-74.
4. Lurbe E, Sorof JM, Daniels SR. Clinical and research aspects of ambulatory blood pressure monitoring in children. J Pediatr. 2004;144:7-16.
5. •• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-76. This report was a milestone paper providing clinicians with scientific evidence regarding blood pressure in children and gave recommendations for diagnosis, evaluation, and treatment of hypertension based on available evidence and consensus expert opinion of the working group.
6. • Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension. 2008;52:433-51. The document summarizes the research and clinical applications of ABPM in children and adolescents and offers recommendations on implementation of ABPM in practice and interpretation of results.
7. •• Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27:1719-42. These guidelines represent a consensus among specialists involved in the detection and control of high blood pressure in children and adolescents. The document synthesizes a considerable amount of scientific data and clinical experience and represents best clinical wisdom, upon which physicians, nurses, and families should base their decisions. They call attention to the burden of hypertension in children and adolescents and its contribution to the current epidemic of cardiovascular disease.
8. Lurbe E, Cremades B, Rodriguez C, Torro MI, Alvarez V, Redon J. Factors related to quality of ambulatory blood pressure monitoring in a pediatric population. Am J Hypertens. 1999;12:929-33.
9. Lurbe E, Redon J, Liao Y, Tacons J, Cooper R, Alvarez V. Ambulatory blood pressure monitoring in normotensive children. J Hypertens. 1994;12:1417-23.
10. Staessen JA, O'Brien ET, Amery AK, Atkins N, Baumgart P, De Cort P, et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens. 1994;12 suppl 7:S1-12.
11. Pannarale G, Bebb G, Clark S, Sullivan A, Foster C, Coats AJS. Bias and variability in blood pressure measurement with ambulatory recorders. Hypertension. 1993;22:591-8.
12. Lurbe E, Cremades B, Torró I, Alvarez V, Tacons J, Redón J. Gender modifies the relationship between awake systolic blood pressure and growth in adolescents. Am J Hypertens. 1998;11(part 2):20A.
13. Lurbe E, Thijs L, Redon J, Alvarez V, Tacons J, Staessen J. Diurnal blood pressure curve in children and adolescents. J Hypertens. 1996;14:41-6.
14. Staessen J, Bulpitt CJ, O'Brien E, Cox J, Fagard R, Stanton A, et al. The diurnal blood pressure profile. A population study. Am J Hypertens. 1992;5:386-92.
15. Pickering TG, Harsfield GA, Kleinert HD, Blank S, Laragh JH. Blood pressure during normal daily activities, sleep and exercise. Comparison of values in normal and hypertensive subjects. JAMA. 1982;247:992-6.
16. Lurbe A, Redon J, Pascual JM, Tacons J, Alvarez V, Batlle DC. Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension. 1993;21:227-35.
17. • Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20:1995-2007. The study provides distribution-independent reference values for time-integrated 24-h, daytime and nighttime mean values of systolic, diastolic and mean arterial BP, as well as of heart rate, in children.
18. Hornsby JL, Mongan PF, Taylor AT, Treiber FA. 'White coat' hypertension in children. J Fam Pract. 1991;33:617-23.
19. Sorof JM, Poffenbarger T, Franco K, Portman R. Evaluation of white-coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens. 2001;14:855-60.
20. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension. 2005;45:493-8.
21. Lurbe E, Redon J. The role of ambulatory blood pressure monitoring in diagnosis of hypertension and evaluation of target-organ damage. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. 2nd ed. New Jersey: Humana Press; 2011. p. 517-28.
22. Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target organ damage. Pediatr Nephrol. 2005;20:1151-5.
23. Matsuoka S, Kawamura K, Honda M, Awazu M. White coat effect and white coat hypertension in pediatric patients. Pediatr Nephrol. 2002;17:950-3.
24. McNiece KL, Gupta-Malhotra M, Samuels J, Bell C, Garcia K, Poffenbarger T, et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension. 2007;50:392-5.
25. Kavey RE, Kveselis DA, Atallah N, Smith FC. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr. 2007;150:491-7.
26. Lande MB, Meagher CC, Fisher SG, Belani P, Wang H, Rashid M. Left ventricular mass index in children with white coat hypertension. J Pediatr. 2008;153:50-4.
27. Stergiou GS, Nasothimiou E, Giovas P, Kapoyiannis A, Vazeou A. Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring. J Hypertens. 2008;26:1556-62.
28. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010;21:137-44.
29. Di Salvo G, Castaldi B, Baldini L, Gala S, del Gaizo F, D'Andrea A, et al. Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function. J Hum Hypertens. 2011;25:739-45.
30. Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol. 2004;19:651-4.
31. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342-9.
32. Bjorklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003;107:1297-302.
33. Lurbe E, Redon J. Assessing ambulatory blood pressure in renal diseases: facts and concerns. Nephrol Dial Transplant. 1999;14:2564-2568.
34. Luik AJ, Struijk DG, Gladziwa U, von Olden RW, von Hooff JP, de Leeuw PW, et al. Diurnal blood pressure variations in haemodyalisis and CAPD patients. Nephrol Dial Transplant. 1994;9:1616-21.
35. Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant. 1997;12:2301-7.
36. Calzolari A, Giordano U, Matteucci M, Pastore E, Turchetta A, Rizzoni G, et al. Hypertension in young patients after renal transplantation: ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens. 1998;11:497-501.
37. Sorof JM, Poffenbarger T, Portman R. Abnormal 24-hour blood pressure patterns in children after renal transplantation. Am J Kidney Dis. 2000;35:681-6.
38. Morgan H, Khan I, Hashmi A, Hebert D, McCrindle B, Balfe JW. Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol. 2001;16:843-7.
39. Mistnefes M, Portman R. Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant. 2003;7:86-92.
40. Li Kam Wa TC, Macnicol AM, Watson ML. Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 1997;12:2075-80.
41. Lama G, Tedesco MA, Graziano L, Calabrese E, Grassia C, Natale F, et al. Reflux nephropaty and hypertension: correlation with the progression of renal damage. Pediatr Nephrol. 2003;18:241-245.
42. Patzer L, Seeman T, Luck C, Wühl E, Janda J, Misselwitz J. Day and night time blood pressure elevation in children with higher grades of renal scarring. J Pediatr. 2003;142:117-22.
43. Lurbe E, Redon J, Pascual JM, Tacons J, Alvarez V. The spectrum of circadian blood pressure changes in type 1 diabetic patients. J Hypertens. 2001;19:1421-8.
44. Malcolm DD, Burns TL, Mahoney LT, Lauer RM. Factors affecting left ventricular mass in childhood: the Muscatine Study. Pediatrics. 1993;92:703-9.
45. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25:1056-62.
46. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation. 1995;91:2400-6.
47. Schieken RM, Schwartz PF, Goble MM. Tracking of left ventricular mass in children: race and sex comparisons: the MCV Twin Study. Medical College of Virginia. Circulation. 1998;97:1901-6.
48. Sivanandam S, Sinaiko AR, Jacobs Jr DR, Steffen L, Moran A, Steinberger J. Relation of increase in adiposity to increase in left ventricular mass from childhood to young adulthood. Am J Cardiol. 2006;98:411-5.
49. Flynn JT, Alderman MH. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol. 2005;20:961-6.
50. Litwin M, Niemirska A, Sladowska J, Antoniewicz J, Daszkowska J, Wierzbicka A, et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol. 2006;21:811-9.
51. Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97:1907-11.
52. Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39:903-8.
53. Belsha CW, Wells TG, McNiece KL, Seib PM, Plummer JK, Berry PL. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens. 1998;11(4 Pt 1):410-7.
54. Richey PA, Disessa TG, Hastings MC, Somes GW, Alpert BS, Jones DP. Ambulatory blood pressure and increased left ventricular mass in children at risk for hypertension. J Pediatr. 2008;152:343-8.
55. Stabouli S, Kotsis V, Rizos Z, Toumanidis S, Karagianni C, Constantopoulos A, et al. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol. 2009;24:1545-51.
56. Jourdan C, Wühl E, Litwin M, Fahr K, Trelewicz J, Jobs K, et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens. 2005;23:1707-15.
57. Lande MB, Carson NL, Roy J, Meagher CC. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension. 2006;48:40-4.
58. Stabouli S, Kotsis V, Karagianni C, Zakopoulos N, Konstantopoulos A. Blood pressure and carotid artery intima-media thickness in children and adolescents: the role of obesity. Hellenic J Cardiol. 2012;53:41-7.
59. •• Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progresión to microalbuminuria in Type 1 diabetes. N Engl J Med. 2002;347:797-805. The study, which involved a cohort of adolescents and young adults with type 1 diabetes, shows that an increase in blood pressure during sleep precedes the development of microalbuminuria.
60. •• ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361:1639-50. Intensified blood pressure control, with target 24-hour blood pressure levels in the low range of normal, confers a substantial benefit with respect to renal function among children with chronic kidney disease. Reappearance of proteinuria after initial successful pharmacologic blood pressure control is common among children who are receiving long-term ACE inhibition.